Vancouver Infectious Diseases Centre
Institution data
| Type | HEALTHCARE (active) |
|---|---|
| Country | Vancouver, CA |
| Works | 7 |
| Researchers | 9 |
| Coverage | 2017 - 2025 |
| ROR | 0159q3366 |
| GRID | grid.498788.2 |
| OpenAlex | I4210100817 |
| Website | http://www.vidc.ca/ |
| Also known as | Vancouver Infectious Diseases Centre |
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver, Canada
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs
No prominent works on this page.
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver, Canada
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
| ARTICLE | 7 |
|---|
| 2025 | 1 |
|---|---|
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 2 |